ArticleJournal of cellular and molecular medicine2021

TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer.

Zaoqu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.